JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

NeoGenomics Inc

Closed

10.63 1.82

Overview

Share price change

24h

Current

Min

10.53

Max

10.69

Key metrics

By Trading Economics

Income

-19M

-45M

Sales

13M

181M

Profit margin

-24.867

Employees

2,200

EBITDA

-41M

-48M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+6.19% upside

Dividends

By Dow Jones

Next Earnings

28 Oct 2025

Market Stats

By TradingEconomics

Market Cap

537M

1.4B

Previous open

8.81

Previous close

10.63

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

NeoGenomics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

24 Oct 2025, 16:25 UTC

Major Market Movers

Obook Shares Rise, Company Secures New Money Transmitter Licenses

23 Oct 2025, 12:37 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Solmate Infrastructure Shares Higher on Acquisition Plans

22 Oct 2025, 16:54 UTC

Major Market Movers

Applied DNA Sciences Shares Rise After Private Investment, Crypto Buys

21 Oct 2025, 13:09 UTC

Earnings
Major Market Movers

Galaxy Digital Shares Jump on Swing to 3Q Profit, Surging Revenue

17 Oct 2025, 15:03 UTC

Major Market Movers

Obook Shares Sink Following Public Debut

24 Oct 2025, 13:16 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

24 Oct 2025, 13:16 UTC

Market Talk

Bitcoin Rises After U.S. Inflation Data Firms Rate Cut Bets -- Market Talk

24 Oct 2025, 06:59 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

24 Oct 2025, 06:59 UTC

Market Talk

Bitcoin Rises on Confirmation of Trump-Xi Meeting -- Market Talk

23 Oct 2025, 07:04 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 Oct 2025, 07:04 UTC

Market Talk

Bitcoin Edges Higher But U.S.-China Tensions Limit Recovery -- Market Talk

22 Oct 2025, 14:05 UTC

Market Talk

Bitcoin Could Briefly Fall Below $100K -- Market Talk

22 Oct 2025, 09:30 UTC

Acquisitions, Mergers, Takeovers

Combination of FalconX, 21Shares to Develop Derivatives, Structured Products -- WSJ

22 Oct 2025, 09:30 UTC

Acquisitions, Mergers, Takeovers

Crypto Trading Firm FalconX to Buy ETF Manager 21Shares -- WSJ

22 Oct 2025, 09:30 UTC

Acquisitions, Mergers, Takeovers

FalconX to Fund 21Shares Deal Using Cash, Stock -- WSJ

22 Oct 2025, 09:30 UTC

Acquisitions, Mergers, Takeovers

FalconX Strikes Deal to Buy Crypto Asset Manager 21Shares -- WSJ

22 Oct 2025, 07:57 UTC

Market Talk

Bitcoin Falls After Confusing U.S.-China Signals -- Market Talk

21 Oct 2025, 10:00 UTC

Acquisitions, Mergers, Takeovers

Deal Set to Come Later Tuesday, Executives Say -- WSJ

21 Oct 2025, 10:00 UTC

Acquisitions, Mergers, Takeovers

Coinbase Strikes Deal for Crypto-Investing Platform Echo -- WSJ

21 Oct 2025, 10:00 UTC

Acquisitions, Mergers, Takeovers

Coinbase Strikes Roughly $375M Deal for Crypto-Investing Platform Echo, Executives Say -- WSJ

21 Oct 2025, 10:00 UTC

Acquisitions, Mergers, Takeovers

Coinbase to Fund Deal Using Cash and Stock, Executives Say -- WSJ

21 Oct 2025, 08:00 UTC

Market Talk

Bitcoin Falls as Recovery Attempts Prove Short-Lived -- Market Talk

20 Oct 2025, 14:30 UTC

Acquisitions, Mergers, Takeovers

Evernorth to Raise Over $1B in SPAC Deal with Armada II

20 Oct 2025, 07:03 UTC

Market Talk

Bitcoin Rises on Hopes For De-Escalation in U.S.-China Tensions -- Market Talk

17 Oct 2025, 10:37 UTC

Market Talk

Bitcoin Extends Losses as Investors Shun Risky Assets -- Market Talk

17 Oct 2025, 07:08 UTC

Market Talk

Bitcoin Falls as U.S. Regional Bank Concerns, U.S.-China Tensions Weigh -- Market Talk

16 Oct 2025, 19:37 UTC

Acquisitions, Mergers, Takeovers

Crypto Industry Dives Deeper Into Prediction Markets as Kraken Buys Exchange -- Barrons.com

16 Oct 2025, 18:31 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 Oct 2025, 18:31 UTC

Market Talk

Global Equities Roundup: Market Talk

16 Oct 2025, 18:31 UTC

Market Talk

Charles Schwab Readies Spot Crypto Trading -- Market Talk

Peer Comparison

Price change

NeoGenomics Inc Forecast

Price Target

By TipRanks

6.19% upside

12 Months Forecast

Average 11.33 USD  6.19%

High 14 USD

Low 8 USD

Based on 10 Wall Street analysts offering 12 month price targets forNeoGenomics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

5

Buy

5

Hold

0

Sell

Technical Score

By Trading Central

7.7 / 10.27Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat